Inthera Blog

Inthera Blog

Pharmaceutical Industry

Comparator drug sourcing: The importance of comparators

Discover Inthera's expert comparator drug sourcing services, ensuring quality and efficiency in clinical trials for reliable healthcare outcomes.

Pharmaceutical Industry

Decentralized clinical trials: revolutionizing clinical research

Explore the advantages of decentralized clinical trials with Inthera's expertise, offering tailored solutions for successful research.

Pharmaceutical Industry

Optimizing pharmaceutical supply chain management: Key players and critical aspects

Pharmaceutical supply chain management - Discover with Inthera how precision and speed transform supply chain efficiency.

Pharmaceutical Industry

The role of pharmacoeconomics in drug development: A strategic investment in value

Discover with Inthera how pharmacoeconomics supports smarter drug development through cost-effectiveness, and evidence-based decision-making.

Pharmaceutical Industry

Revolutionizing Healthcare: The Impact of Personalized Medicine

Personalized medicine is transforming healthcare by using genetic insights to more effective treatments. Learn more in Inthera's article.

Pharmaceutical Industry

The role of strategic partnerships in mitigating drug shortage

Strategic partnerships help fight drug shortage by improving supply chains, ensuring access to quality medicines. Learn more from Inthera!

Pharmaceutical Industry

How personalized medicine is redefining healthcare for every individual

D: Personalized medicine is transforming healthcare by using genetic insights to more effective treatments. Learn more in Inthera's article.

Pharmaceutical Industry

Why pharmaceutical form matter: from tablets to creams

D: Inthera explores how the right pharmaceutical form: pill, capsule, or cream – ensures safe, stable, and effective treatment for every patient.

Pharmaceutical Industry

Designing and conducting a clinical trial from the perspective of the pharmaceutical industry

D: Clinical trial - What aspects should be considered when designing and conducting it from a pharmaceutical perspective? Here are the answers of Inthera!

Pharmaceutical Industry

Good Clinical Practice (GCP): a framework of requirements in human clinical trials

D: Good Clinical Practice (GCP) is an international framework for the conduct and documentation of clinical trials in humans. Learn more from Inthera’s article!

Pharmaceutical Industry

The safety of clinical trials: protecting participants in medical research

D: The safety of clinical trials - Inthera's article summarises how researchers ensure that trials are safe for participants.

Pharmaceutical Industry

What is GLP (Good Laboratory Practice)? - The most important things to know

What is GLP (Good Laboratory Practice), why is it important in the pharmaceutical industry and what are its key principles? Find out in this Inthera article!

Pharmaceutical Industry

The significance of ISO 9001/2015 certification in the pharmaceutical industry

Inthera has obtained ISO 9001/2015 certification. In our blog post, we explain what this means for pharmaceutical industry players.

Pharmaceutical Industry

The clinical trial phase IV: the final stage of the clinical trial

The clinical trial phase IV, the post-marketing study, is the final stage in development. Inthera has complied the key facts about it.

Pharmaceutical Industry

Background, phases, and types of clinical trials

Clinical trials can be categorized into different types, which determine the structure and execution of the trials. Let’s explore the types and phases!

Pharmaceutical Industry

First-in-human trial: The first phase of clinical development

A first-in-human trial is the initial phase of clinical drug development following the completion of the preclinical phase.

Pharmaceutical Industry

Phase II of clinical development: proof of concept clinical study

The second phase of clinical development is the proof of concept clinical study, during which drugs are tested in patients. Here's what you need to know!

Pharmaceutical Industry

Phase III of clinical development: testing efficacy and safety

Phase III of clinical development is designed to test the efficacy and safety of the drug in thousands of patients in as heterogeneous a population as possible.